Actinium Pharmaceuticals, Inc.
ATNM
$1.34
-$0.0475-3.42%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 72.90M | 78.66M | 86.04M | 84.06M | 76.68M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.60M | 860.00K | 1.03M | 1.32M | 1.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 74.51M | 79.52M | 87.07M | 85.37M | 78.26M |
|
|
|||||
| Total Current Assets | 74.51M | 79.52M | 87.07M | 85.37M | 78.26M |
| Net Property, Plant & Equipment | 2.07M | 2.27M | 2.48M | 2.66M | 2.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 324.00K | 322.00K | 318.00K | 316.00K | 313.00K |
| Total Assets | 76.90M | 82.11M | 89.86M | 88.35M | 81.45M |
|
|
|||||
| Total Accounts Payable | 7.57M | 7.20M | 9.18M | 7.51M | 7.95M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 580.00K | 560.00K | 551.00K | 551.00K | 541.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.15M | 7.76M | 9.73M | 8.06M | 8.49M |
|
|
|||||
| Total Current Liabilities | 8.15M | 7.76M | 9.73M | 8.06M | 8.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 993.00K | 1.15M | 1.30M | 1.43M | 1.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.00M | 35.00M | 35.00M | 35.00M | 35.00M |
| Total Liabilities | 44.14M | 43.91M | 46.03M | 44.50M | 45.07M |
|
|
|||||
| Common Stock & APIC | 408.58M | 407.38M | 401.44M | 390.11M | 373.96M |
| Retained Earnings | -375.83M | -369.17M | -357.61M | -346.25M | -337.58M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.76M | 38.21M | 43.84M | 43.86M | 36.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.76M | 38.21M | 43.84M | 43.86M | 36.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.76M | 38.21M | 43.84M | 43.86M | 36.38M |
|
|
|||||
